M&A Deal Summary |
|
|---|---|
| Date | 2021-07-20 |
| Target | Omniome |
| Sector | Life Science |
| Buyer(s) | Pacific Biosciences of California |
| Deal Type | Add-on Acquisition |
| Deal Value | 600M USD |
| Advisor(s) | Jefferies (Financial) Wilson Sonsini Goodrich & Rosati Cooley (Legal) |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 2004 |
| Sector | Life Science |
Pacific Biosciences of California, Inc. offers sequencing systems to help scientists resolve genetically complex problems. Based on its novel Single Molecule, Real-Time (SMRT®) technology, Pacific Biosciences’ products enable: de novo genome assembly to finish genomes in order to more fully identify, annotate and decipher genomic structures; full-length transcript analysis to improve annotations in reference genomes, characterize alternatively spliced isoforms in important gene families, and find novel genes; targeted sequencing to more comprehensively characterize genetic variations; and real-time kinetic information for epigenome characterization. Pacific Biosciences’ technology provides high accuracy, ultra-long reads, uniform coverage, and the ability to simultaneously detect epigenetic changes. PacBio® sequencing systems, including consumables and software, provide a simple, fast, end-to-end workflow for SMRT Sequencing.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 3 |
| Sector: Life Science M&A | 1 of 3 |
| Type: Add-on Acquisition M&A Deals | 1 of 3 |
| State: California M&A | 1 of 2 |
| Country: United States M&A | 1 of 3 |
| Year: 2021 M&A | 1 of 2 |
| Size (of disclosed) | 1 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-08-03 |
Circulomics
Baltimore, Maryland, United States Circulomics is a biotechnology company focused on delivering highly differentiated sample prep products that enable genomic workflows. Circulomics use micro-, nano-, and single-molecule technologies to streamline every step in the genomics workflow from sample preparation to assays and detection instruments. Circulomics was founded in 2009 and is based in Baltimore, Maryland. |
Buy | - |